Welcome
10 January 2009
Trial registration
Unique identification scheme
International databases
home
|
my details
|
ISRCTN Register
|
m
RCT
|
UKCTG
|
links
|
information
|
press
Find trials
ISRCTN Register
tips on searching
Registration
New application
Updating record
Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
International Standard Randomised Controlled Trial Number Register
Showing records:
6871
to
6880
of
7369
SEARCH FOR
RESULTS ORDER
DIRECTION
MAX RESULTS
ISRCTN
Relevance
Sponsor
Date Assigned
Ascending
Descending
10 per page
20 per page
50 per page
6871
A Prospective Randomised Multicentre Phase III Clinical Trial Comparing the Effects of Panorex Injection Plus 5-Fluorouracil (5-FU)/Leucovorin versus 5-Fluorouracil/Leucovorin versus PANOREX alone, in patients with Surgically resected Stage III (Dukes C) Carcinoma of the Colon
ISRCTN:
ISRCTN18439984
Sponsor:
Glaxo Wellcome (UK)
Date assigned:
19 August 2002
6872
A randomised double-blind trial comparing arimidex alone with nolvadex alone with arimidex and nolvadex in combination, as adjuvant treatment in post-menopausal women with breast cancer
ISRCTN:
ISRCTN18233230
Sponsor:
AstraZeneca Clinical Research Group (UK)
Date assigned:
19 August 2002
6873
Laser Treatment Alone versus Laser Treatment plus Brachytherapy for Inoperable Oesophageal Carcinoma
ISRCTN:
ISRCTN64368467
Sponsor:
UK Co-ordinating Committee for Cancer Research (UKCCCR)
Date assigned:
19 August 2002
6874
Protocol for a Randomised Phase II Study of the Stanford V regimen compared with ABVD for the treatment of Advanced Hodgkin's Disease
ISRCTN:
ISRCTN64141244
Sponsor:
British National Lymphoma Investigation - BNLI (UK)
Date assigned:
19 August 2002
6875
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origin
ISRCTN:
ISRCTN63374575
Sponsor:
Royal Marsden Hospital (UK)
Date assigned:
19 August 2002
6876
Prospective Randomised Evaluation of High-Intensity Chemotherapy with Peripheral Blood Progenitor Support in Patients with High Risk Breast Cancer
ISRCTN:
ISRCTN62673495
Sponsor:
Amgen Limited (UK)
Date assigned:
19 August 2002
6877
A Randomised Study of continuous infusion 5-Fluorouracil (5FU) with or without bolus Mitomycin-C in Patients with Advanced Pancreatic Cancer
ISRCTN:
ISRCTN61961630
Sponsor:
Royal Marsden Hospital (UK)
Date assigned:
19 August 2002
6878
EURO-EWING 99: European Ewing Tumour Working Initiative of National Groups
ISRCTN:
ISRCTN61438620
Sponsor:
United Kingdom Children's Cancer Study Group (UK)
Date assigned:
19 August 2002
6879
A randomised trial comparing 8 cycles of CPT11 with CPT11 until disease progression in patients with Colorectal Cancer resistant to 5-Fluorouracil (5FU)
ISRCTN:
ISRCTN59568483
Sponsor:
Royal Marsden Hospital (UK)
Date assigned:
19 August 2002
6880
To Compare Intravenous Treosulphan with Intravenous Treosulphan plus Cisplatin in Advanced Ovarian Cancer
ISRCTN:
ISRCTN59482963
Sponsor:
Leo Pharmaceuticals (UK)
Date assigned:
19 August 2002
RESULT PAGE
|<
<
684
685
686
687
688
689
690
691
692
>
>|
© ISRCTN